Intracameral bevacizumab role in trabeculectomy: A 1-year prospective randomized controlled study.
Gilad RabinaDana BarequetMichael MimouniShimon KurtzGabi ShemeshAmir RosenblattEldar RosenfeldPublished in: European journal of ophthalmology (2019)
Intracameral bevacizumab during mitomycin C trabeculectomy in patients with primary open-angle glaucoma apparently does not improve success rates. The adjuvant use of intracameral bevacizumab is therefore not justified.